Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI).


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
07 05 2022
Historique:
pubmed: 10 2 2022
medline: 11 5 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

Evidence suggests that childhood maltreatment (ie, childhood abuse and childhood neglect) affects educational attainment and cognition. However, the association between childhood maltreatment and Intelligence Quotient (IQ) seems stronger among controls compared to people with psychosis. We hypothesised that: the association between childhood maltreatment and poor cognition would be stronger among community controls than among people with first-episode of psychosis (FEP); compared to abuse, neglect would show stronger associations with educational attainment and cognition; the association between childhood maltreatment and IQ would be partially accounted for by other risk factors; and the association between childhood maltreatment, educational attainment, and IQ would be stronger among patients with affective psychoses compared to those with nonaffective psychoses. 829 patients with FEP and 1283 community controls from 16 EU-GEI sites were assessed for child maltreatment, education attainment, and IQ. In both the FEP and control group, childhood maltreatment was associated with lower educational attainment. The association between childhood maltreatment and lower IQ was robust to adjustment for confounders only among controls. Whereas childhood neglect was consistently associated with lower attainment and IQ in both groups, childhood abuse was associated with IQ only in controls. Among both patients with affective and nonaffective psychoses, negative associations between childhood maltreatment and educational attainment were observed, but the crude association with IQ was only evident in affective psychoses. Our findings underscore the role of childhood maltreatment in shaping academic outcomes and cognition of people with FEP as well as controls.

Sections du résumé

BACKGROUND AND HYPOTHESIS
Evidence suggests that childhood maltreatment (ie, childhood abuse and childhood neglect) affects educational attainment and cognition. However, the association between childhood maltreatment and Intelligence Quotient (IQ) seems stronger among controls compared to people with psychosis. We hypothesised that: the association between childhood maltreatment and poor cognition would be stronger among community controls than among people with first-episode of psychosis (FEP); compared to abuse, neglect would show stronger associations with educational attainment and cognition; the association between childhood maltreatment and IQ would be partially accounted for by other risk factors; and the association between childhood maltreatment, educational attainment, and IQ would be stronger among patients with affective psychoses compared to those with nonaffective psychoses.
STUDY DESIGN
829 patients with FEP and 1283 community controls from 16 EU-GEI sites were assessed for child maltreatment, education attainment, and IQ.
STUDY RESULTS
In both the FEP and control group, childhood maltreatment was associated with lower educational attainment. The association between childhood maltreatment and lower IQ was robust to adjustment for confounders only among controls. Whereas childhood neglect was consistently associated with lower attainment and IQ in both groups, childhood abuse was associated with IQ only in controls. Among both patients with affective and nonaffective psychoses, negative associations between childhood maltreatment and educational attainment were observed, but the crude association with IQ was only evident in affective psychoses.
CONCLUSIONS
Our findings underscore the role of childhood maltreatment in shaping academic outcomes and cognition of people with FEP as well as controls.

Identifiants

pubmed: 35137235
pii: 6524686
doi: 10.1093/schbul/sbac004
pmc: PMC9077421
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

575-589

Subventions

Organisme : Department of Health
Pays : United Kingdom

Investigateurs

Silvia Amoretti (S)
Álvaro Andreu-Bernabeu (Á)
Grégoire Baudin (G)
Stephanie Beards (S)
Chiara Bonetto (C)
Elena Bonora (E)
Bibiana Cabrera (B)
Angel Carracedo (A)
Thomas Charpeaud (T)
Javier Costas (J)
Doriana Cristofalo (D)
Pedro Cuadrado (P)
Manuel Durán-Cutilla (M)
Aziz Ferchiou (A)
David Fraguas (D)
Nathalie Franke (N)
Flora Frijda (F)
Cloe Llorente (C)
Paz Garcia-Portilla (P)
Javier González Peñas (J)
Kathryn Hubbard (K)
Stéphane Jamain (S)
Estela Jiménez-López (E)
Marion Leboyer (M)
Gonzalo López Montoya (G)
Esther Lorente-Rovira (E)
Covadonga M Díaz-Caneja (C)
Camila Marcelino Loureiro (C)
Mario Matteis (M)
Elles Messchaart (E)
Ma Dolores Moltó (MD)
Gisela Mezquida (G)
Carmen Moreno (C)
Roberto Muratori (R)
Nacher Juan (N)
Mara Parellada (M)
Baptiste Pignon (B)
Marta Rapado-Castro (M)
Mirella Ruggeri (M)
Jean-Romain Richard (JR)
José Juan Rodríguez Solano (JJ)
Pilar A Sáiz (PA)
Teresa Sánchez-Gutierrez (T)
Emilio Sánchez (E)
Franck Schürhoff (F)
Marco Seri (M)
Rosana Shuhama (R)
Simona A Stilo (SA)
Fabian Termorshuizen (F)
Anne-Marie Tronche (AM)
Daniella van Dam (D)
Elsje van der Ven (E)

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

J Am Acad Child Adolesc Psychiatry. 1997 Mar;36(3):340-8
pubmed: 9055514
Schizophr Res Cogn. 2020 May 19;21:100179
pubmed: 32461919
Front Psychiatry. 2021 Mar 08;12:596949
pubmed: 33762975
J Am Acad Child Adolesc Psychiatry. 2016 Jan;55(1):33-40.e3
pubmed: 26703907
Horm Behav. 2006 Nov;50(4):632-9
pubmed: 16876168
Neuropsychology. 2009 May;23(3):315-36
pubmed: 19413446
Schizophr Bull. 2021 Jul 8;47(4):975-985
pubmed: 33836526
Br J Psychiatry. 2017 Aug;211(2):88-94
pubmed: 28642258
Dev Psychobiol. 2021 Mar;63(2):153-172
pubmed: 32227350
Compr Psychiatry. 2017 Jul;76:147-152
pubmed: 28528230
Psychol Bull. 2007 Sep;133(5):833-58
pubmed: 17723032
Psychol Med. 2015 Oct;45(13):2727-36
pubmed: 26350397
J Trauma Dissociation. 2018 Oct-Dec;19(5):552-571
pubmed: 29125800
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Neuropsychology. 1998 Jul;12(3):426-45
pubmed: 9673998
Front Hum Neurosci. 2012 Mar 19;6:52
pubmed: 22457645
JAMA Psychiatry. 2020 Jul 1;77(7):755-765
pubmed: 32159746
Schizophr Bull. 2014 Mar;40 Suppl 2:S138-46
pubmed: 24371326
PLoS One. 2014 Apr 04;9(4):e93994
pubmed: 24705808
Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
Soc Psychiatry Psychiatr Epidemiol. 2020 May;55(5):645-657
pubmed: 31974809
Schizophr Bull. 2016 Jan;42(1):77-86
pubmed: 26231719
BMC Psychiatry. 2015 Aug 25;15:205
pubmed: 26302744
Am J Psychiatry. 2017 Nov 1;174(11):1075-1085
pubmed: 27978770
Acta Psychiatr Scand. 2006 Jul;114(1):55-61
pubmed: 16774662
Clin Psychol Rev. 2007 May;27(4):409-24
pubmed: 17222489
Lancet Psychiatry. 2018 Jul;5(7):591-604
pubmed: 29773478
Arch Gen Psychiatry. 1991 Aug;48(8):764-70
pubmed: 1883262
Schizophr Bull. 2014 Nov;40(6):1509-17
pubmed: 24345517
Child Abuse Negl. 2019 Dec;98:104236
pubmed: 31683250
Front Psychiatry. 2011 Jul 28;2:48
pubmed: 21847382
Neuropsychol Rev. 2018 Dec;28(4):509-533
pubmed: 30343458
Psychol Med. 2018 Feb;48(3):392-403
pubmed: 28735586
Schizophr Bull. 1982;8(3):470-84
pubmed: 7134891
JAMA Psychiatry. 2019 Jun 1;76(6):584-593
pubmed: 30892562
Psychol Med. 2018 Oct;48(13):2186-2193
pubmed: 29268811
Schizophr Bull. 2017 Mar 1;43(2):316-324
pubmed: 28177077
Psychopharmacology (Berl). 2011 Mar;214(1):367-75
pubmed: 20838776
Cogn Neuropsychiatry. 2013;18(6):574-93
pubmed: 23167265
JAMA Psychiatry. 2018 Jan 1;75(1):36-46
pubmed: 29214289
Psychol Med. 2015 Jan;45(2):381-94
pubmed: 25065268
Child Abuse Negl. 2020 Sep;107:104603
pubmed: 32599461
Schizophr Res. 2021 May 15;:
pubmed: 34006427
Schizophr Res. 2011 Jun;129(1):12-9
pubmed: 21601792
Schizophr Res. 2004 Dec 1;71(2-3):405-16
pubmed: 15474912
Schizophr Bull. 2011 Jul;37(4):768-77
pubmed: 19934212
Curr Psychiatry Rep. 2004 Jun;6(3):168-75
pubmed: 15142469
Am J Psychiatry. 2017 Apr 1;174(4):349-361
pubmed: 27794691
Psychol Med. 2020 Aug;50(11):1761-1782
pubmed: 32624020
Schizophr Bull. 2020 Apr 10;46(3):517-529
pubmed: 31361020
Schizophr Bull. 2020 Feb 26;46(2):336-344
pubmed: 31206164
Psychol Med. 2020 Sep;50(12):1966-1976
pubmed: 32744193
Schizophr Bull. 2009 May;35(3):603-23
pubmed: 18658128
Neurosci Biobehav Rev. 2011 Jan;35(3):573-88
pubmed: 20620163
Schizophr Bull Open. 2020 Jan;1(1):sgaa041
pubmed: 32984820
Trauma Violence Abuse. 2015 Oct;16(4):418-37
pubmed: 24920354
Psychopharmacology (Berl). 2011 Mar;214(1):121-30
pubmed: 21107538
Neurosci Biobehav Rev. 2017 Jan;72:68-86
pubmed: 27851897
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1011-22
pubmed: 24919446
Lancet. 2009 Jan 3;373(9657):68-81
pubmed: 19056114
Eur Psychiatry. 2014 Jan;29(1):32-5
pubmed: 23764407
Am J Psychiatry. 1997 Nov;154(11):1544-50
pubmed: 9356562
Front Psychiatry. 2014 Jan 08;4:182
pubmed: 24409157
Lancet Psychiatry. 2019 May;6(5):427-436
pubmed: 30902669
Schizophr Bull. 2019 Oct 24;45(6):1195-1208
pubmed: 30376115
JAMA Psychiatry. 2020 Jul 1;77(7):729-736
pubmed: 32159742
Psychiatry Res. 2012 Aug 15;198(3):495-500
pubmed: 22472845
Compr Psychiatry. 2016 Jul;68:86-96
pubmed: 27234188
Schizophr Res. 2000 Dec 15;46(2-3):209-15
pubmed: 11120433
Mol Psychiatry. 2021 Aug;26(8):4529-4543
pubmed: 33414498
Soc Psychiatry Psychiatr Epidemiol. 2015 Oct;50(10):1511-8
pubmed: 26099998

Auteurs

Lucia Sideli (L)

Department of Human Science, LUMSA University, Rome, Italy.
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.

Adriano Schimmenti (A)

Faculty of Human and Social Sciences, UKE - Kore University of Enna, Enna, Italy.

Daniele La Barbera (D)

Department of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Caterina La Cascia (C)

Department of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Laura Ferraro (L)

Department of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Monica Aas (M)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.
NORMENT, Centre for Research On Mental Disorders, Oslo University Hospital and University of Oslo, Norway.
Department of Mental Health Research and Development, Division of Mental Health and Addiction, Vestre Viken Hospital Trust, Norway.

Luis Alameda (L)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.
Departamento de Psiquiatria, Centro Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocio, Universidad de Sevilla, Sevilla, Spain.

Eva Velthorst (E)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.
Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, USA.
Early Psychosis Section, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Helen L Fisher (HL)

King's College London, Social, Genetic, & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, London, England.
ESRC Centre for Society and Mental Health, King's College London, London, UK.

Vincenzo Caretti (V)

Department of Human Science, LUMSA University, Rome, Italy.

Giulia Trotta (G)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.

Giada Tripoli (G)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.
Department of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Diego Quattrone (D)

King's College London, Social, Genetic, & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, London, England.

Charlotte Gayer-Anderson (C)

King's College London, Social, Genetic, & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, London, England.
Department of Health Services and Population Research, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.

Fabio Seminerio (F)

Department of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Crocettarachele Sartorio (C)

Department of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Giovanna Marrazzo (G)

Department of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, Palermo, Italy.

Antonio Lasalvia (A)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.

Sarah Tosato (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.

Ilaria Tarricone (I)

Department of Medical and Surgical Sciences, Alma Mater Studiorum - Bologna University, Italy.

Domenico Berardi (D)

Department of Biomedical and NeuroMotor Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy.

Giuseppe D'Andrea (G)

Department of Biomedical and NeuroMotor Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy.

Celso Arango (C)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, ISGM, CIBERSAM, Madrid, Spain.

Manuel Arrojo (M)

Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago, Spain.

Miguel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Hospital Clinic, Department of Medicine, Neuroscience Institute, University of Barcelona, Institut d'Investigacions Biomèdiques, August Pi I Sunyer, Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain.

Julio Bobes (J)

Department of Medicine, Psychiatry Area, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, Oviedo, Spain.

Julio Sanjuán (J)

Department of Psychiatry, Centro de Investigación Biomédica en Red de Salud Mental, School of Medicine, Universidad de Valencia, Valencia, Spain.

Jose Luis Santos (JL)

Department of Psychiatry, Hospital "Virgen de la Luz", Cuenca, Spain.

Paulo Rossi Menezes (PR)

Department of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Cristina Marta Del-Ben (CM)

Division of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, Universidade de São Paulo, São Paulo, Brazil.

Hannah E Jongsma (HE)

PsyLife Group, Division of Psychiatry, University College London, London, England.
Department of Psychiatry, University of Cambridge, Cambridge, England.

Peter B Jones (PB)

CAMEO Early Intervention Service, Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge, England.
EA 7280 Npsydo, Université Clermont Auvergne, Clermont-Ferrand, France.

James B Kirkbride (JB)

PsyLife Group, Division of Psychiatry, University College London, London, England.

Pierre-Michel Llorca (PM)

EA 7280 Npsydo, Université Clermont Auvergne, Clermont-Ferrand, France.

Andrea Tortelli (A)

Establissement Public de Santé, Maison Blanche, Paris, France.

Baptiste Pignon (B)

AP-HP, Groupe Hospitalier "Mondor," Pôle de Psychiatrie, Créteil, France.
Institut National de la Santé et de la Recherche Médicale, U955, Créteil, France.
Fondation Fondamental, Créteil, France.

Lieuwe de Haan (L)

Early Psychosis Section, Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands.

Jean-Paul Selten (JP)

Institute for Mental Health, GGZ Rivierduinen, Leiden, The Netherlands.
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

Jim Van Os (J)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department Psychiatry, Utrecht University Medical Centre, Utrecht, The Netherlands.

Bart P Rutten (BP)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

Marta Di Forti (M)

King's College London, Social, Genetic, & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, London, England.

Craig Morgan (C)

ESRC Centre for Society and Mental Health, King's College London, London, UK.
Department of Health Services and Population Research, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.

Robin M Murray (RM)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH